J, C., L, M., J, M. B., A, M., & B, P. (2019). Real-world retrospective comparison of 0.19 mg fluocinolone acetonide and 0.7 mg dexamethasone intravitreal implants for the treatment of diabetic macular edema in vitrectomized eyes. Dove Medical Press.
Cita Chicago Style (17a ed.)J, Coelho, Malheiro L, Melo Beirão J, Meireles A, y Pessoa B. Real-world Retrospective Comparison of 0.19 Mg Fluocinolone Acetonide and 0.7 Mg Dexamethasone Intravitreal Implants for the Treatment of Diabetic Macular Edema in Vitrectomized Eyes. Dove Medical Press, 2019.
Cita MLA (8a ed.)J, Coelho, et al. Real-world Retrospective Comparison of 0.19 Mg Fluocinolone Acetonide and 0.7 Mg Dexamethasone Intravitreal Implants for the Treatment of Diabetic Macular Edema in Vitrectomized Eyes. Dove Medical Press, 2019.